Nuvectis Pharma Announces Proposed Public Offering of Common Stock
Nuvectis Pharma (NASDAQ: NVCT) has announced a proposed public offering of its common stock, with the underwriters granted an option to purchase up to 15% more shares. The company plans to use proceeds for advancing development programs and operational costs.
Topics: biopharmaceutical company capital raising public offering